Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
about
An Overview and Update of Chronic Myeloid Leukemia for Primary Care PhysiciansTyrosine kinase inhibitors and pregnancy.Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy.Gonadotoxic Effects of Nilotinib in Chronic Myeloid Leukemia Treatment Dose in a Mouse ModelPrincipal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester.Will imatinib compromise reproductive capacity?A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11)(q34;q11.2;q13)How I treat childhood CML.Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy.Clinical review: kinase inhibitors: adverse effects related to the endocrine system.The Tyrosine Kinase Inhibitor Sunitinib Affects Ovulation but Not Ovarian Reserve in Mouse: A Preclinical StudyTherapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid LeukemiaHow I treat newly diagnosed chronic phase CMLThe effects of imatinib on pregnancy outcomeA Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg TabletsEffects of chemotherapy and radiotherapy on spermatogenesis in humans.Maternal GIST in twin pregnancy: Case report of a rare and complex management challengeTwo successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.The impact of dasatinib on pregnancy outcomes.Successful pregnancy and delivery in a patient with chronic myeloid leukemia: a case report and review of the literature.Use of tyrosine kinase inhibitors for chronic myeloid leukemia: management of patients and practical applications for pharmacy practitioners.Cancer chemotherapeutic agents as human teratogens.Twin pregnancy and childbirth after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation combined with imatinib mesylate for chronic myeloid leukaemia: case report and literature review.Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.Managing pregnancy in chronic myeloid leukaemia.Adverse effects of common medications on male fertility.Management of Hematologic Malignancies: Special Considerations in Pregnant Women.Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports.Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia.Management of pregnant chronic myeloid leukemia patients.Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy.The teratogenic effects of imatinib mesylate on rat fetuses.Germline mutations in ABL1 cause an autosomal dominant syndrome characterized by congenital heart defects and skeletal malformations.Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response.Successful management of pregnancy occurring in a patient with chronic myeloid leukemia on dasatinib.Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy.Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia.Pregnancy in patients with chronic myeloid leukemia treated with imatinib.
P2860
Q26782165-9974C63C-77CA-4ADD-84B7-88389AEF57B4Q33568481-E05CC972-BF8E-4969-A09F-AC6EC0B00E78Q33708377-C59C5589-3AF3-4977-8B3F-692592142702Q33716491-94492F14-3604-4B74-87CC-7FFCDAA8C1EBQ34443523-EE9341A9-0F62-44F8-B4A6-72E5A1B389BDQ34523506-168F96AD-6AEB-449A-BAEA-E9C5CB78D5E2Q35584349-6DE9E345-D38F-42A6-BE63-EC4DEBC936C3Q35720048-D7D8D8B7-5BC9-4091-9419-62DF8005BA86Q35802202-6F005BF1-9152-45C1-A2DC-8DEA2B868422Q36094702-033F48E3-4A57-4976-B4FE-9D6592C83D39Q36736494-DA56B328-DB38-4B50-9FD6-7233321E11BDQ36757329-6EB44374-593A-41F4-A2D4-706E30B37FBDQ36822880-2F13FCB3-E7F9-45C8-96E4-5C8AE6003107Q36880864-14081AC0-610B-4F5E-A75D-6B44E8FC11A0Q37027767-0C787512-82C3-4501-AE7D-F3CB4C6AE3CBQ37028624-90C22E83-7221-4295-B81B-D747BED72E45Q37097538-F59FEA21-A2F4-4895-B2FB-6992CD2D3F55Q37305907-6272DA63-6738-4C38-BBE0-F2A2E2AF2DB0Q37387628-5754276A-0079-40DC-9B72-F026789C95E3Q37389662-C3063D01-DE78-428B-9F8F-E9A7BAEDBC9FQ37423501-80173C15-2A61-439D-A8E0-79ED953E246EQ37459133-C7D15A15-F2D3-4ED3-BA41-1DA308C14B00Q37889508-CE1A28D8-E3C3-41F3-98F0-2EB3C319EB21Q38031187-83A69AE1-54D9-4938-B5F6-20A699AC281CQ38074219-765FDED9-EFE0-4452-9D09-639B2E81F1A5Q38087930-D05BEEEB-13A2-4038-943D-22F12457E7B3Q38392686-CFD7AC97-B875-4A99-8BFE-8EF6F2CC7CFFQ38534996-7D843979-3979-453F-AF06-7AEC2C1AB758Q38594889-E83DD052-DEC3-4132-A91C-20A5B3D520DDQ38666371-DA018554-D538-4084-AF26-F25E3A06E1E3Q38813874-B7E91B09-22AB-4639-AE8E-903558845B6EQ38879793-21AC0BBD-C6A7-4E66-BA62-48A7847BE92BQ41534360-40F795D8-F262-4DBD-8F3A-5D9793A988BCQ41680312-F458D513-5170-43C7-8EED-BAD22CCCBCD0Q41757658-7F9B1CF8-1CEB-4398-A916-30EFE88A99DFQ42531379-6248C340-063D-41BD-AD8A-6D75CF178AEEQ42970801-72BF7E77-18B5-46B7-AD02-CCD3AE6DC250Q43901048-6A741181-826B-41DB-80EC-46D66909ED0DQ45833965-64B9EA92-9999-42D5-9075-A59556BB47E1Q46860346-7F7FA86C-C917-425B-933C-1A38A05284CD
P2860
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
@en
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
@nl
type
label
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
@en
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
@nl
prefLabel
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
@en
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
@nl
P2093
P50
P356
P1476
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
@en
P2093
Charles Koller
Miloslav Beran
Moshe Talpaz
Patricia Ault
P304
P356
10.1200/JCO.2005.04.6557
P407
P50
P577
2006-01-30T00:00:00Z